160 related articles for article (PubMed ID: 23553575)
1. Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder.
Bahali K; Ipek H; Uneri OS
Eur Child Adolesc Psychiatry; 2013 Oct; 22(10):649-50. PubMed ID: 23553575
[No Abstract] [Full Text] [Related]
2. [The practice and problem of therapeutic agents for AD/HD].
Tanaka H; Miyajima T
No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
[No Abstract] [Full Text] [Related]
3. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Jaworowski S; Benarroch F; Gross-Tsur V
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
[TBL] [Abstract][Full Text] [Related]
4. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Husarova V; Bittsansky M; Ondrejka I; Dobrota D
Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
[TBL] [Abstract][Full Text] [Related]
5. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatments of hyperactive child].
Le Heuzey MF
Arch Pediatr; 2004 Jan; 11(1):64-9. PubMed ID: 14700769
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Stuhec M; Munda B; Svab V; Locatelli I
J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
[TBL] [Abstract][Full Text] [Related]
8. How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.
van Wyk GW; Hazell PL; Kohn MR; Granger RE; Walton RJ
J Atten Disord; 2012 May; 16(4):314-24. PubMed ID: 21289234
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
Hanwella R; Senanayake M; de Silva V
BMC Psychiatry; 2011 Nov; 11():176. PubMed ID: 22074258
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.
Reichow B; Volkmar FR; Bloch MH
J Autism Dev Disord; 2013 Oct; 43(10):2435-41. PubMed ID: 23468071
[TBL] [Abstract][Full Text] [Related]
11. Update on drugs for hyperactivity in childhood.
Drug Ther Bull; 2007 May; 45(5):37-40. PubMed ID: 17536494
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adult ADHD and comorbid disorders.
Young JL
CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
[No Abstract] [Full Text] [Related]
13. Methylphenidate vs atomoxetine: personalized medicine in attention- deficit/hyperactivity disorder.
Heinrich H; Studer P; Moll GH; Kratz O
JAMA Psychiatry; 2013 May; 70(5):545. PubMed ID: 23636880
[No Abstract] [Full Text] [Related]
14. Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial.
Ghanizadeh A; Haghighat R
Pediatr Nephrol; 2012 Nov; 27(11):2091-2097. PubMed ID: 22700161
[TBL] [Abstract][Full Text] [Related]
15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of ADHD in adults.
Wilens TE
CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
[No Abstract] [Full Text] [Related]
17. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
18. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D
Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888
[TBL] [Abstract][Full Text] [Related]
19. [My child is so restless].
Schlamp D
MMW Fortschr Med; 2007 Mar; 149(10):39-40. PubMed ID: 17408047
[TBL] [Abstract][Full Text] [Related]
20. A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain.
Hong J; Dilla T; Arellano J
BMC Psychiatry; 2009 Apr; 9():15. PubMed ID: 19366449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]